Worried About Automation? 'Human-in-the-Loop' Protocols Offer Comfort and New Opportunities

Posted by Mike Jakymiw on Thu, Oct 31, 2019

Satish Jha co-wrote this post with Mike Jakymiw

Keeping someone “in the loop” means keeping them informed or involved. The term human-in-the-loop (HITL) means involving humans in processes that leverage innovations like AI, robotics and machine-learning algorithms. HITL ensures that a process isn’t run automatically without human supervision. On the surface, this might seem like distrust of automation and AI, but it’s a layer of precaution used to avoid mistakes or misses that AI and robots can easily make. More importantly, HITL will enhance these processes.


>
Read More

How Do Doctors Feel About Robots in the Exam Room?

Posted by Paul Darling on Wed, Aug 29, 2018

This blog post is the first in a series on ZS’s 2018 AI in Healthcare study.

Data-rich, technology-based solutions like artificial intelligence are lining up to transform many facets of healthcare, but before we start planning for the transformation that this technology can bring, we might want to do a reality check: Will AI truly be disruptive in an industry that has been slow to adopt new technologies, or will the change be incremental? And even if AI can improve care delivery, what do doctors—and patients—think about inviting AI into the exam room?


>
Read More

Is AI in Pharma Ready to Move From Hype to Hope?

Posted by Pratap Khedkar on Thu, Jan 11, 2018

This is the first post in a three-part series on artificial intelligence in healthcare. 

We encounter artificial intelligence platforms outside of healthcare on a regular basis, like when we ask Siri a question or view Netflix’s list of suggested films. However, within healthcare, and in the pharmaceutical industry specifically, AI has yet to live up to that level of success. In the near future, will AI become embedded in pharma R&D? Will it enable treatment decisions to be more automated—and more accurate? I recently called my colleague John Piccone, a ZS principal and advanced data science expert who previously led IBM Watson Health’s life sciences offerings, to discuss AI’s use both within pharma and throughout the healthcare ecosystem.


>
Read More

Three Common Challenges When Launching a Marketing Automation Tool—and How to Overcome Them (Part One)

Posted by Jim Anderson on Mon, Jun 06, 2016

In my colleague Pete Mehr’s article, “Campaign Management: New Tools + Old Process = Time to Change!", he describes how cloud-based campaign management tools are being under-utilized in the pharmaceutical industry, and calls out a few areas that can be challenging. In this post, we’ll dive into one of the areas and outline some approaches to remedy them. In part two of this blog post, we’ll discuss two more of these roadblocks.


>
Read More